CTIS2024-513306-65-00进行中（未招募）1 期
Safety and potential effect of innovative treatment by adjuvant injection of stromal vascular Fraction from autologous adipose tissue of URethral stenosis with endoscopic urethrotomy: randomized controlled trial - SURF
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- Male
入选标准
- •Signed informed consent, Male, aged from 18 to 85 years, Bulbar urethral stenosis = 3 cm Although there is no concensus on a clear definition of what a significant bulbar UrS is to date, a significant Bulbar UrS will be defined as 3 dimension entity for the study: - A narrowing of urethra that does not accept a standard flexible fibroscope (CH16) to pass through - In a patient with bothersome voiding and/or storage symptoms or any complication (infection, retention) who is asking for a relief - Qmax = 15 ml/s AND USP ICIQ male LUTS voiding dysfunction domain ? 0 (Zero), At least one urethral dilatation or urthrotomy for the bulbar stenosis in the past 24 months before diagnosis of stenosis, Ability to avoid corticoids or immunosuppressive drugs one month after treatment, Good general health status according to clinical history and a physical examination, BMI > 18 to insure adequate access to abdominal or other subcutaneous adipose tissue for adipose tissue harvesting
排除标准
- •Urethral stenosis of other location than bulbar, Contraindication to the anaesthetic or surgical procedure, Corticoids or immunosuppressive drugs > 3 months, Any active viral infection among the following: HIV, HTLV I and II, VHB, VHC and Syphillis, Administrative restricted rights, Urethral stenosis length > 3 cm, Urethral stenosis on reconstructed penis (transgender, post amputation), Prior perineal or pelvic radiotherapy, Concurent urinary tract infection without treatment, Concurent perineal infection, Penile cancer < 5 years, Current or recent history of abnormal, severe, progressive, uncontrolled infectious, hepatic, haematological, gastrointestinal (except CD), endocrine, pulmonary, cardiac, neurological, psychiatric, or cerebral disease, Congenital or acquired immunodeficiencies
研究者
相似试验
尚未招募
2 期
The INTEGRATE study: an adaptive platform trial for the development of new interventions to combat Lassa Fever in West Africa.Lassa FeverPACTR202312770983740Irrua Specialist Teaching Hospital732
进行中（未招募）
1 期
Evaluation the safety and efficacy of the treatment of scars and cutis laxa syndrome with the use of autologous (fresh and stored) stem cells isolated from adipose tissue within the project: 'The therapeutic potential of mesenchymal stem cells tested in clinical trials and in vitro - a justification for characterized cells storage'.EUCTR2016-004110-10-PLMedical University of Warsaw100
尚未招募
1 期
Will treating the overwhelming patient response with medications affect COVID-19 mortality?COVID-19Respiratory - Other respiratory disorders / diseasesInflammatory and Immune System - Other inflammatory or immune system disordersInfection - Other infectious diseasesACTRN12620000731998SW Health via the Hunter New England Local Health District36
尚未招募
4 期
The evaluation of efficacy and safety in modification to new immunosuppressant (tacrolimus hydrate:Graceptor) from the current immunosuppressive therapy after liver transplantatioJPRN-UMIN000001649Graduate School of Medicine, Osaka University Department of Surgery20
招募中
不适用
Comparison of anterior versus posterior approch for myotomy in Per Oral Endoscopic Myotomy (POEM) in treatment of Achalasia CardiaCTRI/2016/05/006949Asian Institute Of Gastroenterology60